Sign In
Buy BLCO
$14.87
-0.110 (-0.734%)
At Close: Jun 03, 2026
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
05:44pm, Monday, 01'st Jun 2026
Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
06:59am, Monday, 01'st Jun 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
07:15am, Thursday, 21'st May 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
04:49pm, Wednesday, 20'th May 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the election o
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
08:57am, Wednesday, 13'th May 2026
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets.
Bausch + Lomb Announces Second R&D “Teach-in” Webinar
07:15am, Wednesday, 06'th May 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the second eve
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
07:00am, Thursday, 30'th Apr 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will d
Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript
05:01pm, Wednesday, 29'th Apr 2026
Bausch + Lomb Corporation (BLCO) Q1 2026 Earnings Call Transcript
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates
09:25am, Wednesday, 29'th Apr 2026
Bausch + Lomb (BLCO) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.07 per share a year ago.
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
06:58am, Wednesday, 29'th Apr 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quar
Bausch + Lomb Releases 2025 Sustainability Impact Report
07:15am, Wednesday, 22'nd Apr 2026
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the release of
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-k
Comparing Biodesix (NASDAQ:BDSX) & Bausch + Lomb (NYSE:BLCO)
04:32am, Friday, 10'th Apr 2026
Biodesix (NASDAQ: BDSX - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati
Bausch + Lomb Corporation (NYSE:BLCO) Receives Average Rating of “Hold” from Analysts
02:23am, Tuesday, 31'st Mar 2026
Shares of Bausch + Lomb Corporation (NYSE: BLCO - Get Free Report) have been given an average recommendation of "Hold" by the fifteen ratings firms that are covering the firm, MarketBeat Ratings repor
